Results 111 to 120 of about 19,199 (220)

CAR‐Engineered Cell Therapies Beyond Cancer: Reprogramming Fibrosis and Immune‐Mediated Inflammation

open access: yesAdvanced Science, Volume 13, Issue 54, 28 September 2026.
CAR‐engineered cell therapies are expanding beyond cancer toward immune resetting, pathological‐cell clearance, matrix remodeling, and microenvironmental reprogramming in autoimmune, inflammatory, and fibrotic diseases. This Review compares CAR‐T, CAR‐macrophage, and CAR‐NK platforms and proposes controllable spatiotemporal reprogramming to align ...
Peng Jun Xu   +6 more
wiley   +1 more source

Timing of DAS28 in infliximab therapy [PDF]

open access: yesRheumatology, 2005
D. J. Armstrong, I. N. Bruce
openaire   +1 more source

Proteomics‐Based Identification of the Pyroptosis‐Related Biomarker PCSK9 and Its Association With the Pathogenesis of Rheumatoid Arthritis

open access: yesThe Kaohsiung Journal of Medical Sciences, Volume 42, Issue 9, September 2026.
ABSTRACT Rheumatoid arthritis (RA) is a common autoimmune disease, and early diagnosis is critical for effective treatment. This study aims to identify potential biomarkers related to pyroptosis through serum proteomics analysis, offering new insights for the early diagnosis of RA.
Lei Wang   +10 more
wiley   +1 more source

The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia

open access: yes, 2018
To determine the contribution of fibromyalgia (FM) to the subjective components of the Disease Activity Score 28-joints (DAS28) in patients with rheumatoid arthritis (RA), and to analyse the discriminatory performance of the derived DAS28 patient ...
Sarzi-Puttini, Piercarlo   +3 more
core   +1 more source

Autoimmunity: Molecular Mechanisms, Biomarkers, and Therapeutic Opportunities

open access: yesMedComm, Volume 7, Issue 9, September 2026.
Major types of immunometabolism, epigenetics, posttranscriptional regulation, and functional reprogramming involved in autoimmune diseases. The roles of immunometabolism, epigenetics, posttranscriptional regulation, and functional reprogramming in autoimmune diseases have been a major research focus in recent years.
Jialong Kuang   +10 more
wiley   +1 more source

AUC of ROC- curves for HAQ, SF-36 and DAS28.

open access: yes, 2014
Areas under the curve (AUC) of the ROC curve analysis performed with HAQ, SF-36, SF-36 physical component score (PCS) and DAS28 for the social support measures available in Belgium in order to assess whether these instruments can be used to predict the ...
Saskia Decuman (625939)   +2 more
core   +1 more source

Patient Experiences and Preliminary Effects of Virtual Reality Based Pain Treatment in Rheumatoid Arthritis Patients With Persistent Pain Despite Low Disease Activity: A Mixed Method Pilot Study

open access: yesMusculoskeletal Care, Volume 24, Issue 3, September 2026.
ABSTRACT Objective This study aimed to examine the acceptability, usability, patient perceptions and preliminary effects of a virtual reality (VR) based pain management programme for people with rheumatoid arthritis with persistent pain despite low disease activity.
Stijn J. M. Temmink   +7 more
wiley   +1 more source

Indice auto-DAS28 versus DAS28. Validez de la autoevaluación del paciente en la práctica diaria

open access: yes, 2018
El DAS28 (Disease Activity Score 28-joint counts) ha sido empleado profusamente en la investigación clínica para cuantificar la actividad y la evolución en pacientes con artritis reumatoide (AR). Actualmente, se considera deseable una mayor participación
Badía Flores, Jorge J.   +2 more
core  

Course of DAS28 and prednisolone dosage under therapy.

open access: yes, 2015
Bars represent the median (75% quartiles) of DAS28 and prednisolone dosage over time.
Markus Gaubitz (32011)   +6 more
core   +1 more source

Cystatin D as a biomarker for rheumatoid arthritis: relation to disease activity and joint damage

open access: yesRheumatology
Introduction Rheumatoid arthritis (RA) is a multisystem autoimmune disorder. Autoantibody levels in the serum of RA patients can guide the diagnosis and treatment. Cystatin D is a known inhibitor of cathepsins involved in RA pathogenesis.
Ola Mounir   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy